VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 17 filers reported holding VANECK VECTORS ETF TR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $84,967 | +15.2% | 2,740 | 0.0% | 0.01% | +16.7% |
| Q3 2023 | $73,733 | -53.3% | 2,740 | -47.7% | 0.01% | -53.8% |
| Q2 2023 | $157,776 | -6.9% | 5,240 | 0.0% | 0.01% | -13.3% |
| Q1 2023 | $169,514 | +377.0% | 5,240 | +322.6% | 0.02% | +400.0% |
| Q4 2022 | $35,538 | +18.5% | 1,240 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $30,000 | -11.8% | 1,240 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $34,000 | -41.4% | 1,240 | -18.4% | 0.00% | -33.3% |
| Q1 2022 | $58,000 | +132.0% | 1,520 | +94.9% | 0.01% | +100.0% |
| Q4 2021 | $25,000 | +8.7% | 780 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $23,000 | -14.8% | 780 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $27,000 | +8.0% | 780 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $25,000 | +400.0% | 780 | +290.0% | 0.00% | +200.0% |
| Q3 2017 | $5,000 | -50.0% | 200 | -60.0% | 0.00% | -50.0% |
| Q4 2016 | $10,000 | -95.6% | 500 | -94.1% | 0.00% | -95.1% |
| Q3 2016 | $225,000 | – | 8,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |